MetaCap

Silence Therapeutics Plc American Depository Share Balance Sheet

NASDAQ: SLNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

9.86+0.34 (+3.57%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Silence Therapeutics Plc American Depository Share financial position

At the end of fiscal 2025, Silence Therapeutics Plc American Depository Share reported total assets of $131.4 million, down 35.1% from a year earlier against total liabilities of $69.1 million. Shareholders' equity stood at $62.3 million, or 47.4% of assets. The company held $11.3 million in cash and equivalents.

The current ratio (current assets divided by current liabilities) was 8.72, meaning short-term assets cover obligations due within a year.

Summary generated from market data by MetaCap's automated system. Methodology

Silence Therapeutics Plc American Depository Share balance sheet (annual)

Silence Therapeutics Plc American Depository Share annual balance sheet
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20222022-12-31
Cash & Equivalents11.28M121.33M68.79M—
Short-Term Investments73.84M26.00M——
Receivables0972.00K290.00K—
Total Current Assets118.66M187.37M103.15M—
Property, Plant & Equipment1.58M1.82M1.94M—
Goodwill10.62M9.39M9.98M9.68M
Intangible Assets288.00K312.00K——
Total Assets131.44M202.63M119.45M—
Accounts Payable4.41M3.70M3.35M—
Total Current Liabilities13.61M16.82M22.34M—
Total Liabilities69.14M68.61M97.45M—
Shareholders' Equity62.30M134.02M21.99M27.22M
Retained Earnings-562.57M-474.04M-431.89M—
Net Cash (Debt)85.11M147.33M68.79M—
Shares Outstanding141.70M141.67M118.85M107.81M

This table shows 4 annual periods of Silence Therapeutics Plc American Depository Share's balance sheet, from FY 2025 back to FY 2022, across 15 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow SLN's reporting calendar. What is a balance sheet?

More financial data